-
Start Preamble
ACTION:
Notice of application.
DATES:
Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before October 28, 2019.
ADDRESSES:
Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.
End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
Start Printed Page 44918
In accordance with 21 CFR 1301.33(a), this is notice that on July 17, 2019, Nanosyn Inc., 3331 Industrial Drive, Suite B, Santa Rosa, California 95403-2062 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances:
Controlled Substance Drug Code Schedule Fentanyl 9801 II Oxymorphone 9652 II The company is a contract manufacturer. At the request of the company's customers, it manufactures derivatives of controlled substances in bulk form.
Start SignatureDated: August 9, 2019.
Neil D. Doherty,
Acting Assistant Administrator.
[FR Doc. 2019-18454 Filed 8-26-19; 8:45 am]
BILLING CODE 4410-09-P
Document Information
- Published:
- 08/27/2019
- Department:
- Drug Enforcement Administration
- Entry Type:
- Notice
- Action:
- Notice of application.
- Document Number:
- 2019-18454
- Dates:
- Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before October 28, 2019.
- Pages:
- 44917-44918 (2 pages)
- Docket Numbers:
- Docket No. DEA-392
- PDF File:
- 2019-18454.Pdf